Dr Wanner brings more than 20 years of regional and international leadership experience across R&D, regulatory strategy, laboratory operations, and product commercialization. He has led global scientific teams, built innovation centers, and guided organizations from concept through successful market launch.
At MicroCare, Dr Wanner will oversee the innovation pipeline, direct formulation and product development, strengthen regulatory strategy, and support scalable manufacturing processes while collaborating closely with cross-functional teams.
Prior to joining the company, he held senior leadership roles at Drew Marine, Symbiotic Research (Tentamus Group), and Arysta LifeScience. He holds a Doctorate from The University of Bonn and an MBA from Fairfield University, graduating top of his class.
“Uwe’s combination of scientific depth, strategic vision, and global leadership experience will play a critical role in ensuring our continued innovation and long-term growth,” commented Venesia Hurtubise, Vice President of Technology and Compliance at the company. “His ability to translate complex scientific challenges into scalable commercial solutions aligns perfectly with our mission to deliver precision chemistry with confidence,” Hurtubise added.
Commenting on his new role, Dr Wanner said, “I am excited to join MicroCare and contribute to a culture that values expertise, creativity, and innovation. Together, we will continue to strengthen the company’s product portfolio and support customers with reliable, forward-thinking solutions.”
